C07C 247/08
Being unsaturated
Official title: being unsaturated
C07C247/08 (Being unsaturated) appears on 110 US grants and 64 published applications in this corpus.
Search patents in C07C- Granted patents
- 110
- Published applications
- 64
- Assignees
- 71
- Inventors
- 210
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 6 | 0 |
| 1995 | 1 | 0 |
| 1996 | 16 | 0 |
| 1997 | 20 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 2 |
| 2002 | 2 | 2 |
| 2003 | 3 | 3 |
| 2004 | 1 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 3 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 2 | 3 |
| 2010 | 1 | 3 |
| 2011 | 1 | 3 |
| 2012 | 2 | 3 |
| 2013 | 2 | 4 |
| 2014 | 2 | 3 |
| 2015 | 1 | 4 |
| 2016 | 5 | 4 |
| 2017 | 1 | 2 |
| 2018 | 1 | 2 |
| 2019 | 5 | 4 |
| 2020 | 6 | 4 |
| 2021 | 2 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 3 |
| 2024 | 0 | 1 |
| 2025 | 4 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures23 Dec 2025US 12,503,428 B2Ligand Pharmaceuticals Incorporated
- Method for synthesis of diazabicyclo[6.2.0]decane related compounds23 Sep 2025US 12,421,246 B2Eisai R&D Management Co., Ltd.
- Crystals of 3-hydroxy-N'-(1,3-dimethylbutylidene)-2-naphthoic acid hydrazide and production method for the same2 Sep 2025US 12,404,233 B2Otsuka Chemical Co., Ltd.
- Hexasubstituted benzenes, surfaces modified therewith, and associated methods24 Jun 2025US 12,338,196 B2Countertrace LLC
- Method and molecules19 Sep 2023US 11,759,526 B2MedImmune, LLC
- Method for synthesis of diazabicyclo[6.2.0]decane related compounds14 May 2026US 2026/0132144 A1Eisai R&D Management Co., Ltd.
- A continuous flow process for synthesis of organic azides20 Nov 2025US 2025/0353811 A1Indian Institute of Science Education and Research, Pune (IISER Pune)
- Method And Molecules15 May 2025US 2025/0152728 A1MedImmune, LLC
- Apyrase inhibitors28 Mar 2024US 2024/0101510 A1
- Method And Molecules12 Oct 2023US 2023/0321267 A1MedImmune, LLC
Most cited
By later US patents
- Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents217US 5,688,819 AAllergan, Inc. · 1997
- Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents177US 6,403,649 B1Allergan Sales, Inc. · 2002
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents111US 5,352,708 AAllergan, Inc. · 1994
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994